We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Conducting Fewer Bioresearch Inspections Under Risk-Based Approach
FDA Conducting Fewer Bioresearch Inspections Under Risk-Based Approach
July 5, 2012
The FDA conducted 949 bioresearch monitoring inspections in fiscal 2011 — 220 fewer inspections than in the previous year — with the decrease spread among all relevant agency centers as they move to a more risk-based approach.